Significados de objective tumor em inglês

Twenty-nine patients (73%) had a clinical objective tumor response after induction treatment.

None of the patients experienced objective tumor regression, including those patients with colonized tumors.

Purpose: Treatment with ipilimumab can cause objective tumor responses in patients with metastatic melanoma.

The primary endpoint was confirmed objective tumor response.

This article investigates the relationship between objective tumor response and sphincter preservation in low rectal carcinoma patients.

No objective tumor responses were seen.

No objective tumor regressions were noted.

There were no objective tumor responses.

However, phase I studies of MAb directed against glycolipid antigens have yielded objective tumor shrinkage with occasional complete responses.

Two patients had objective tumor responses (complete response, liver metastases from unknown primary; partial response, colon cancer).

However, no objective tumor responses were noted, and all 25 patients had progressive disease as their best response to therapy.

There was no difference in immune monitoring results between patients with an objective tumor response and those without a response.

Coumarin is an investigational new drug that has produced objective tumor regression in some patients with metastatic renal cell carcinoma and malignant melanoma.

Conclusions: Combination of CRS-207 and chemotherapy induced significant changes in the local tumor microenvironment and objective tumor responses in a majority of treated patients.

The World Health Organization definitions for objective tumor response published in the 1979 WHO Handbook have been the most commonly used criteria around the world.

This phase II study was designed to determine the objective tumor response rate and toxicity when pemetrexed was administered immediately after gemcitabine on day 1.